돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 16933생성일: 2026년 10월 24일

Methyl Isocyanate → Temozolomide

https://huagongshe.com/ko/reaction/16933

반응식

참여 물질

역할이름HCID투입량
반응물Methyl IsocyanateHCID 12228—
반응물4-amino-1H-imidazole-2-carboxamideHCID 21983288—
반응물5-diazo-1H-imidazole-4-carboxamideHCID 136377446—
용매DichloromethaneHCID 6344—
생성물TemozolomideHCID 5394—

반응 단계

In this process, 5-amino-1H-imidazole-carboxamide (A) is converted into 5-diazo-1H-imidazole-4-carboxamide (B), which is then cyclized with methylisocyanate in dichloromethane to provide a high yield of clinical-grade Temozolomide. However, this process requires isolation of the unstable and potentially dangerous 5-diazo-1H-imidazole-4-carboxamide (B). Moreover, methylisocyanate is a difficult reagent to handle and ship, especially on the industrial scale, and indeed is better avoided in industrial manufacture. Furthermore, the cycloaddition of methylisocyanate requires a very long reaction time: Table I in J. Med. Chem. 1984, 27, 196-201, suggests 20 days.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07737284B2
출처 데이터셋uspto-grants-2010_06
ORD IDord-d39ed1e4e8d04f3592ef23528a553348
출처 메모uspto-grants-2010_06